SBIR/STTR Research Award
Synthesis of the Novel Anti-HIV Agent Calanolide A.
Award amount
$733,495Program and phase
SBIR · Phase IIAward year
1995Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- MEDICHEM LIFE SCIENCES
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
The recently discovered class of remarkably effective anti-HIV-1 natural products known as the calanolides are extremely difficult to obtain from natural sources. We herein propose a total synthesis of calanolide A, the most potent of the compounds reported. What is proposed is more than a natural product synthesis. It is necessary to develop an economical process for preparing significant quantities of the calanolides. A clinically successful compound in the series might eventually need to be synthesized in ton quantities to treat the large number of AIDS patients worldwide. A synthesis of calanolide A must allow for structural modification, since the intact natural product is very difficult to modify. This will lay the groundwork for the synthesis of analogues, which may be even more potent and exhibit fewer side effects than the parent natural product.
Technology keywords
Not reported